MilliporeSigma is collaborating with Massachusetts Institute of Technology’s Center for Collective Intelligence and Community Biotechnology Initiative to crowdsource expertise and answers in crucial areas for pandemic response. Here, find the latest media assets and content from events, reports and ongoing initiatives.
Mask Innovations for Virus Transmission Control
Advances in face mask technology, like color-changing N95s and novel surface coatings, could improve the efficacy and accessibility of these tools. Head of bioprocessing R&D David Beattie joined Massachusetts Institute of Technology’s David Sun Kong and McGovern Institute’s Jill Crittenden for a virtual discussion.
Harnessing Data, Diligence and Collective Intelligence
Monitoring viral spread, accelerating clinical trials and delivering health equity are essential to a strong pandemic response. Former CEO Udit Batra and head of the Life Science Innovation Board Patrick Schneider joined Boston Medical Center’s Kate Walsh, Genpact’s Gianni Giacomelli and Massachusetts Institute of Technology’s David Sun Kong for a virtual discussion on the most promising ideas, crowdsourced from 180 experts around the world, to combat COVID-19.
Innovations in Diagnostics and Detection on the Road to Re-densification
Early detection of COVID-19 can enable the world’s gradual return to regular activity. Head of Diagnostic Solutions Yves Dubaquie joined Sonde Health’s Jim Harper, Biobot Analytics’ Mariana Matus and Massachusetts Institute of Technology’s David Sun Kong for a virtual discussion on testing options and developing technologies, like vocal biomarkers and sewage monitoring, that can track viral spread.
Vaccines and Therapies and the Need for Speed
The world is investing in rapid development of vaccines and therapies for COVID-19. Head of chemistry R&D Jehangir Mistry and head of process solutions services R&D Audrey Chang join independent consultant David Onions, Bill & Melinda Gates Medical Research Institute’s Jared Silverman and messagingLab’s Karl Schmieder for a virtual discussion on safe, effective strategies – like open science, unified standards and new testing methods – to accelerate clinical trials.